Letzte Suchanfragen
Ergebnisse für *
Zeige Ergebnisse 1 bis 25 von 64.
-
Intellectual Property in the EU-MERCOSUR FTA
a brief review of the negotiating outcomes of a long-awaited agreement -
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU
the need to rebalance -
Designing pro-health competition policies in developing countries
-
Practical implications of "vaccine nationalism"
a short-sighted and risky approach in response to COVID-19 -
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
-
TRIPS flexibilities on patent enforcement
lessons from some developed countries relating to pharmaceutical patent protection -
Re-thinking global and local manufacturing of medical products after COVID-19
-
Reconsidérations sur la fabrication mondiale et locale de produits médicaux après le COVID-19
-
Data in legal limbo: ownership, sovereignty, or a digital public goods regime?
-
Misappropriation of genetic resources and associated traditional knowledge: challenges posed by intellectual property and genetic sequence information
-
TRIPS flexibilities and TRIPS-plus provisions in the RCEP chapter on intellectual property: how much policy space is retained?
-
Interpreting the flexibilities under the TRIPS agreement
-
A theory of socially-inefficient patent holdout
-
On the interaction between patent screening and its enforcement
-
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
-
Special Section 301: US interference with the design and implementation of national patent laws
-
Equitable access to COVID-19 related health technologies
a global priority -
La judicialización del derecho a la salud
-
Estudio preliminar del capítulo sobre propiedad intelectual del acuerdo MERCOSUR - UE
-
Non-violation and situation complaints under the TRIPS Agreement
implications for developing countries -
Public health and plain packaging of tobacco
an intellectual property perspective -
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
-
Guía para la concesión de licencias obligatorias y uso gubernamental de patentes farmacéuticas
-
The comprehensive and progressive agreement for the trans-pacific partnership
data exclusivity and access to biologics -
Intersección entre competencia y patentes
hacia un ejercicio pro-competitivo de los derechos de patente en el sector farmacéutico